July 26, 2016

CPMA Unveils Regulatory Amendments

June 30, 2016 - The proposed amendments to the ‘Pari-Mutuel Betting Supervision Regulations’ have been pre-published in the ‘Canada Gazette,’ Part 1, as of June 11, 2016 for a 45-day comment period.

Pre-publication in the Canada Gazette is the first step toward promulgation of regulations.

Click here for the complete announcement and description of the proposed changes.

The CPMA has identified a number of changes to the Regulations that would help ensure a relevant and comprehensive regulatory framework for supervising the conduct of pari-mutuel betting in Canada on horse racing. Proposed regulatory amendments include the following:

  • Extending the duration for which betting permits and betting theatre licences may be issued, for up to three years;
  • Clarifying the betting information that race-course associations must make available to the betting public;
  • Identifying a secondary source for exchange rates so that bets made in less common currencies may be converted to Canadian dollars and comingled in Canadian hosted betting pools;
  • Opening betting accounts in provinces that do not conduct horse racing;
  • Establishing requirements for conducting separate pool betting;
  • Clarifying the requirements for the CPMA’s Equine Drug Control Program;
  • Making changes that address inconsistencies in the French and English versions of the Regulations;
  • Repealing the regulation that allows Standardbred Canada and the United States Trotting Association to fulfill certain responsibilities related to the conduct of pari-mutuel betting in a province that has not otherwise established an organization to regulate horse racing; and
  • Adding the drug cobalt to section 2 of the schedule to the Regulations.

Les modifications proposées au ‘Règlement sur la surveillance du pari mutuel’ ont été pré-publié dans la ‘Gazette du Canada,’ Partie 1, en date du 11 juin, 2016 pour une période de commentaires de 45 jours.

La publication préalable dans la Gazette du Canada est la première étape vers la promulgation de règlements. S’il vous plaît visitez le site Web suivant pour la description complète des changements proposés: http://www.gazette.gc.ca/rp-pr/p1/2016/2016-06-11/html/reg1-fra.php.

L’ACPM a proposé un certain nombre de modifications au Règlement qui aideraient à mettre en place un cadre de réglementation pertinent et exhaustif pour la surveillance du pari mutuel au Canada sur les courses de chevaux. Les modifications proposées comprennent ce qui suit :

  • Prolonger jusqu’à trois ans la période pour laquelle des permis de pari et des permis de pari en salle peuvent être délivrés;
  • Clarifier les renseignements sur les paris que les associations d’hippodromes doivent mettre à la disposition des parieurs;
  • Désigner une seconde source de référence de taux de change pour que les paris effectués en devises moins courantes puissent être convertis en dollars canadiens et incorporés dans les poules de pari tenues au Canada;
  • Ouvrir des comptes de pari dans les provinces qui ne tiennent pas de courses de chevaux;
  • Établir des exigences pour la tenue de paris séparés;
  • Clarifier les exigences relatives au Programme de contrôle des drogues équines de l’ACPM;
  • Apporter des modifications pour corriger les écarts entre la version française et la version anglaise du Règlement;
  • Abroger les dispositions réglementaires qui permettent à Standardbred Canada et à la United States Trotting Association d’assumer certaines responsabilités à l’égard de la conduite d’activités de pari mutuel dans une province où il n’existe pas d’organisme de réglementation des courses de chevaux;
  • Ajouter la drogue cobalt à l’article 2 de l’annexe du Règlement.

(With files from the CPMA)
(Standardbred Canada)

Delayed Implementation of 2016 Elimination Guidelines

April 7, 2016 – This is further to the CPMA notice to industry dated March 31st, 2016, respecting the delayed implementation of the 2016 Elimination Guidelines.

We have received a number of inquiries from industry participants asking about the changes to the withdrawal guidelines for the drugs Clenbuterol and Methylprednisolone.

This memo confirms that as mentioned in our March 31st, 2016 notice, official samples will be tested and certificates will be issued for results inconsistent with the Schedule of Drugs 2011 guidelines.  This includes the guidelines for Clenbuterol and Methylprednisolone.

Given the number of changes made to in the 2016 Elimination Guidelines, we believe this to be the most equitable approach to adopt for the transition period.

However, the CPMA reiterates that this approach is being taken in order to assist the industry in transitioning to the new guidelines and urges all industry participants to adjust their practices so as to comply with the new 2016 Elimination Guidelines, which will come into effect on May 1st, 2016.

For further information, contact the CPMA toll free at 1-800-268-8835 or by Email: cpmawebacpm@agr.gc.ca.

Sincerely,

Steve Suttie

 

(CPMA)

Delayed Implementation of 2016 Elimination Guidelines

March 31, 2016 - Since the implementation of the 2016 Elimination Guidelines on March 1, 2016, the CPMA has received reports of an increased number of detections from therapeutic medications, in particular the drug prednisolone. The reason for these results is unknown but they could be attributed to the use of compounded medications, veterinary practices not consistent with the new guidelines or a lack of awareness by stakeholders of the changes.

For this reason, the CPMA is urging all trainers, owners and veterinarians to familiarize themselves with all the changes in the 2016 version of the Elimination Guidelines Booklet as soon as possible and make the necessary modifications of their practices to avoid positive tests. On its part, the CPMA is delaying the implementation of the new guidelines until May 1, 2016 to allow additional time for the horse racing industry to comply with the changes.

Until that time, official samples will continue to be tested and positive certificates will be issued for results inconsistent with the Schedule of Drugs 2011 guidelines.

Effective May 1, 2016, positive certificates will be issued under the new guidelines.

For further information, contact the CPMA toll free at 1-800-268-8835 or by Email: cpmawebacpm@agr.gc.ca

Sincerely,

Steve Suttie

 

Depuis la mise en application des directives du Guide d’élimination 2016 le 1er mars 2016, l’ACPM a reçu des rapports faisant état d’un nombre accru de cas de détection de médicaments thérapeutiques et plus particulièrement de la drogue prednisolone. La raison de ces résultats est inconnue; toutefois, ils pourraient être attribuables à l’utilisation de médicaments composés, à des pratiques vétérinaires non conformes aux nouvelles directives ou au fait que certains intervenants ne sont pas au courant des modifications.

En conséquence, l’ACPM recommande à  tous les entraîneurs, propriétaires et vétérinaires de se familiariser dès que possible avec toutes les modifications dans la version 2016 du Guide d’élimination et à modifier leurs pratiques pour éviter que les tests de dépistage donnent des résultats positifs. De son côté, l’ACPM reporte l’application des nouvelles directives au 1er mai 2016 pour permettre à l’industrie des courses de chevaux d’avoir le temps de se conformer aux modifications.

Entre-temps, l’analyse d’échantillons officiels se poursuivra et des certificats d’analyse positive seront émis si le résultat est non conforme aux directives  de l’Annexe des drogues de 2011.

À compter du 1er mai 2016, des certificats d’analyse positive seront émis conformément aux nouvelles directives.

Pour de plus amples renseignements, communiquez avec l’ACPM au numéro sans frais 1-800-268-8835 ou par courriel à cpmawebacpm@agr.gc.ca.

Cordialement,

Steve Suttie

 

 

 

Reminder: CPMA Guideline Change

January 4, 2015 – On Monday, October 19, officials with the Canadian Pari-Mutuel Agency issued a memo to all Canadian racing bodies announcing that the elimination guidelines for Methylprednisolone will change effective January 1, 2016.

In its release, the CPMA stated that the elimination of Methylprednisolone from a horse can take an extended period of time and that owners and trainers should govern themselves accordingly.

Additionally, the CPMA states that owners and trainers should always consult their own veterinarian for advice and guidelines.

A copy of the memo – which appears in both English and French – can be accessed by clicking here.

(Standardbred Canada)

CPMA Guideline Change for Methylprednisolone

Jan. 1, 2016 – On Monday, October 19, officials with the Canadian Pari-Mutuel Agency issued a memo to all Canadian racing bodies announcing that the elimination guidelines for Methylprednisolone will change effective January 1, 2016.

In its release, the CPMA stated that the elimination of Methylprednisolone from a horse can take an extended period of time and that owners and trainers should govern themselves accordingly.

Additionally, the CPMA states that owners and trainers should always consult their own veterinarian for advice and guidelines.

A copy of the memo – which appears in both English and French – can be accessed byclicking here.

Methylprednisolone Guideline Change

October 21, 2015 – On Monday, October 19, officials with the Canadian Pari-Mutuel Agency issued a memo to all Canadian racing bodies announcing that the elimination guidelines for Methylprednisolone will change effective January 1, 2016.

In its release, the CPMA stated that the elimination of Methylprednisolone from a horse can take an extended period of time and that owners and trainers should govern themselves accordingly.

Additionally, the CPMA states that owners and trainers should always consult their own veterinarian for advice and guidelines.

A copy of the memo – which appears in both English and French – can be accessed byclicking here.

CPMA Ractopamine Clarification

September 1, 2015 - On Tuesday, September 1, the Canadian Pari-Mutuel Agency (CPMA) issued a further notice to the Canadian horse racing industry in regard to ractopamine.

The notice states that the CFIA’s ‘Type A’ commercial feed facility designation is limited to the drug ractopamine and means that the feed facility does not have ractopamine on its premises. However, it is important to note that this designation does not prevent such a facility from having other drugs on its premises that may be prohibited under the Canadian Pari-Mutuel Betting Supervisions Regulations.

The release also states that Type A commercial feed facilities are not the only feed facilities that do not use ractopamine. There are other feed mills that do not have this designation that may be drug free and therefore would not have ractopamine on their premises.

The release concludes by stating that it remains the responsibility of owners and trainers to ensure that the horse feed and supplements they use are free from substances that may result in a positive test under the Regulations.

The contents of the release appear below.


Ractopamine in Feedstuffs – Clarification

This is further to the notices to industry issued by the Canadian Pari-Mutuel Agency (CPMA) regarding the use of ractopamine in feedstuffs and, more specifically, theAugust 21, 2015 update respecting the Canadian Food Inspection Agency’s Canadian Ractopamine Free Certification Program and the identification of Type A commercial feed facilities.

The CPMA wishes to clarify that the CFIA’s Type A commercial feed facility designation is limited to the drug ractopamine and means that the feed facility does not have ractopamine on its premises. However, it is important to note that this designation does not prevent such a facility from having other drugs on its premises that may be prohibited under the Canadian Pari-Mutuel Betting Supervisions Regulations (the Regulations).

In addition, Type A commercial feed facilities are not the only feed facilities that do not use ractopamine. There are other feed mills that do not have this designation that may be drug free and therefore would not have ractopamine on their premises.

The CPMA does not endorse any particular type of facility and does not provide any type of guarantee with respect to any feed supplier, its products or its facilities. It remains the responsibility of owners and trainers to ensure that the horse feed and supplements they use are free from substances that may result in a positive test under the Regulations.


Related Stories

• August 27: Purina’s Comments On The CPMA Ractopamine Update
• Sharpe: Letter Regarding Ractopamine
• CPMA Update On Ractopamine

New Clenbuterol Rules Now In Effect

September 1, 2015 - The Canadian Pari-Mutuel Agency has issued an important reminder to the Canadian horse racing industry that a significant change to the elimination guideline for Clenbuterol will come into effect September 1. The change states that the current elimination guideline for Clenbuterol will be increased from 72 hours to 168 hours (seven days).

The main points from the CPMA’s changes to the elimination guidelines are as follows:

  1. The current elimination guideline for the 0.40 mg oral dose given twice daily for 5 days of clenbuterol (Ventipulmin) contained in the 2011 edition of the Schedule of Drugs booklet will be increased from 72 hours to 168 hours (7 days).
  2. CPMA is temporarily removing the elimination guideline for the 0.30 mg intravenous single administration until further studies are completed.
  3. The 0.32 mg oral single administration will no longer have an elimination guideline.

To view a copy of the CPMA’s memorandum, click here.

The CPMA has announced that the changes will come into effect on September 1, 2015.

The contents of the memorandum appear below.


This memo is to inform the horse racing industry of upcoming changes to the elimination guidelines for CLENBUTEROL.

Specifically:

  1. The current elimination guideline for the 0.40 mg oral dose given twice daily for 5 days of clenbuterol (Ventipulmin) contained in the 2011 edition of the Schedule of Drugs booklet will be increased from 72 hours to 168 hours (7 days).
  2. CPMA is temporarily removing the elimination guideline for the 0.30 mg intravenous single administration until further studies are completed.
  3. The 0.32 mg oral single administration will no longer have an elimination guideline.

There are several medications that may be used as alternatives for clenbuterol. The CPMA provides elimination guideline for some of these substances in the 2011 Schedule of Drugs.

To allow ample time for the industry to adjust to the new elimination guidelines, these changes will come into effect on September 1, 2015 and will be reflected in the next version of the Schedule of Drugs booklet expected to be released later this year.

As always, the CPMA recommends that owners and trainers consult their own veterinarian for advice and guidance in the use of all drugs.


La présente vise à informer l’industrie des courses de chevaux de la modification des lignes directrices d’élimination du CLENBUTEROL.

Plus précisément :

  1. La ligne directrice d’élimination actuelle pour la dose orale de 0,40 mg de clenbuterol (Ventipulmin) donnée deux fois par jour pendant cinq jours indiqué dans l’Annexe des drogues 2011 (brochure) passera de 72 heures à 168 heures (sept jours).
  2. L’ACPM supprime temporairement la ligne directrice d’élimination pour la dose unique de 0,30 mg par intraveineuse jusqu’à ce que plus d’études soient complétées.
  3. La dose orale unique de 0,32 mg ne sera plus assortie d’une ligne directrice d’élimination.

Plusieurs médicaments peuvent être utilisés à la place du clenbuterol. L’ACPM fournit des lignes directrices d’élimination pour certaines de ces substances dans l’Annexe des drogues de 2011.

Afin que l’industrie ait le temps de s’adapter aux nouvelles directives d’élimination, les modifications susmentionnées prendront effet le 1er septembre 2015 et seront incluses dans la prochaine version de l’Annexe des drogues, qui devrait être publiée plus tard cette année.

Comme toujours, l’ACPM recommande que les propriétaires et les entraîneurs consultent leur vétérinaire pour se faire conseiller sur l’utilisation de toutes les drogues.

(CPMA)
(Standardbred Canada)

 

Statement On Ractopamine In Feedstuffs

August 25, 2015 - This memo is to comment on the CPMA press release issued on Friday, August 21st, regarding “Ractopamine In Feedstuffs Update”.

In the press release, the CPMA “reminds race horse owners and trainers that it remains their responsibility to obtain horse feed and supplements that are free from substances that may trigger a positive test such as ractopamine.” It goes on to suggest that “Race horse trainers and owners may wish to obtain their feed from facilities that have been designated as Type A which are those commercial facilities that manufacture, handle and/or distribute only feeds that do not contain ractopamine.” The press release then gives a CFIA link to view the status of mills involved in the Canadian Ractopamine-Free Pork Certification program.

While we commend the efforts of CPMA to bring awareness to the issue of safe manufacturing of feed by avoiding purchasing feed supplied by mills that include Ractopamine in their production, the list provided by CFIA is far from being inclusive in safe options available to Ontario’s horsemen. The list does not include any of the drug-free equine production facilities in Ontario, such as Agribrands Purina in Strathroy, Brooks Feeds in Port Perry, and Sharpe Farm Supplies in Moffat. None of these plants are listed on the CFIA website as they do not manufacture pig feed, hence are not part of the CFIA Canadian Ractopamine-Free Pork Program. These plants are completely drug-free, not just Ractopamine free, offering zero chance of feed contamination from medications, which puts them in a classification far above any type A or B designation when it comes to feed safety! To be a Type A plant, the feed mill cannot use Ractopamine in their manufacturing, but can use a number of other medications in the feed mill such as Rumensin, which is deadly to horses. For complete feed safety, horsemen should be asking for more than just a Type A designation of their feed supplier.

Paul Sharpe
Sharpe Farm Supplies

(Standardbred Canada)

CPMA Update On Ractopamine

Friday, August 21, 2015 - On Friday, August 21, the Canadian Pari-Mutuel Agency issued a memo to the Canadian horse racing industry which contained an update regarding Ractopamine in ‘feedstuffs.’

An official copy of the memo can be accessed by clicking here.

The contents to the memo appear below in both English and French.


Ractopamine In Feedstuffs Update

This memo is further to our notices to industry on February 14 and November 3, 2014, on the subject of ractopamine in feedstuffs wherein we reminded race horse owners and trainers that it remains their responsibility to obtain horse feed and supplements that are free from substances that may trigger a positive test such as ractopamine.

Please be advised that the Canadian Food Inspection Agency (CFIA) has published a list of commercial feed facilities enrolled in the Canadian Ractopamine-Free Pork Certification Program. Race horse trainers and owners may wish to obtain their feed from facilities that have been designated as Type A which are those commercial facilities (feed mills and feed retail outlets) that manufacture, handle and/or distribute only feeds that do not contain ractopamine. They have never manufactured and/or distributed mixed feeds containing ractopamine (including trucking) or have followed the protocols established by CFIA to clean-up their facility.

The list, along with information regarding the Canadian Ractopamine-Free Pork Certification Program can be viewed here. Please note that this list is being updated as new facilities enroll.

Should you have any questions, please contact the CPMA at 1-800-268-8835, or by email at cpmawebacpm@agr.gc.ca.